News | November 14, 2013

Two Studies Demonstrate Efficacy for Prostate Cancer Treated With CyberKnife System

UCLA researchers evaluate long-term outcomes of more than 1,000 patients from multiple institutions

clinical trial study radiation therapy prostate technology accuray cyberknife
November 14, 2013 — Accuray Inc. announced the publication of two papers stemming from a large multi-center study of CyberKnife stereotactic body radiotherapy (SBRT) led by investigators at the University of California, Los Angeles (UCLA). 
 
The first paper, published in the September 2013 online issue of Radiotherapy & Oncology (commonly referred to as the Green Journal), found, in more than 1,000 patients with organ-confined prostate cancer, relapse-free survival rates were comparable to other established treatments at both three- and five-year intervals post-treatment. The second paper published in the October 10 issue of the International Journal of Radiation Oncology (commonly referred to as the Red Journal) demonstrated that CyberKnife SBRT (stereotactic body radiation therapy) was a well-tolerated treatment that allowed patients to return to their pre-treatment health-related quality of life (QoL).
 
“These studies confirm with a much larger patient population and longer follow-up what many smaller studies have already suggested: SBRT is an effective method for treating prostate cancer,” said Christopher King, Ph.D., M.D., professor of radiation oncology and urology, UCLA School of Medicine and lead author of the study. “Compact dose delivery and real-time tracking of prostate motion gave the authors of these studies the confidence to explore the potential of high-dose, extreme hypofractionation. Clinical outcomes so far validate the effectiveness and safety of treating patients with prostate cancer with minimal disruption to their lives.”
 
In the first paper from the study published in the Green Journal, titled, “Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials,” 1,100 patients with low-, intermediate- or high-risk prostate cancer were treated with the CyberKnife System and followed for a median of 36 months. Relapse-free survival rates were comparable to or better than other established treatments at both three- and five-year intervals post-treatment. Additionally, for the 135 patients with at least five years follow-up, disease-free survival was 99 percent for low-risk and 93 percent for intermediate-risk patients. 
 
In the second paper, “Health related quality of life after stereotactic body radiotherapy for localized prostate cancer,” published in the Red Journal, health-related QoL was assessed in 864 patients after prostate SBRT on the CyberKnife System. Reductions in urinary and bowel QoL recovered to baseline levels or better within six months and remained so over the long term. Sexual QoL declined in the first nine months in a manner that was no worse than that seen with other modern approaches to radiation therapy and observed in other studies. Overall, the QoL outcomes compared favorably to surgery and other kinds of radiotherapy.
 
The CyberKnife is equipped with the InTempo Adaptive Imaging System, which enables real-time tracking and correcting of the prostate during treatment. This image-guidance technology ensures the CyberKnife is on target, sparing normal tissue despite unpredictable, sometimes extensive prostate movement.
 

Related Content

RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Transpara Deep Learning Software Matches Experienced Radiologists in Mammogram Reading
News | Computer-Aided Detection Software | January 12, 2018
Deep learning and artificial intelligence improves the efficiency and accuracy of reading mammograms, according to...
Smartphone Addiction Creates Imbalance in Brain
News | Mobile Devices | January 11, 2018
Researchers have found an imbalance in the brain chemistry of young people addicted to smartphones and the internet,...
Fat Distribution in Women and Men Provides Clues to Heart Attack Risk
News | Women's Health | January 11, 2018
January 11, 2018 – It’s not the amount of fat in your body but where it is stored that may increase your risk for hea
Minimally Invasive Treatment Provides Relief from Back Pain

Lumbar spine MRI showing disc herniation and nerve root at baseline and one month after treatment

News | Interventional Radiology | January 11, 2018
The majority of patients were pain free after receiving a new image-guided pulsed radiofrequency treatment for low back...
Emergency Radiologists See Inner Toll of Opioid Use Disorders

Rates of Imaging Positivity for IV-SUDs Complications. Image courtesy of Efren J. Flores, M.D.

News | Clinical Study | January 11, 2018
January 11, 2018 – Emergency radiologists are seeing a high prevalence of patients with complications related to opio
CT Shows Enlarged Aortas in Former Pro Football Players

3-D rendering from a cardiac CT dataset demonstrating mild dilation of the ascending aorta.

News | Computed Tomography (CT) | January 11, 2018
Former National Football League (NFL) players are more likely to have enlarged aortas, a condition that may put them at...
Study Finds No Evidence that Gadolinium Causes Neurologic Harm

MR images through, A, C, E, basal ganglia and, B, D, F, posterior fossa at level of dentate nucleus. Images are shown for, A, B, control group patient 4, and the, C, D, first and, E, F, last examinations performed in contrast group patient 13. Regions of interest used in quantification of signal intensity are shown as dashed lines for globus pallidus (green), thalamus (blue), dentate nucleus (yellow), and pons (red).

News | Contrast Media | January 11, 2018
January 11, 2018 — There is no evidence that accumulation in the brain of the element gadolinium speeds cognitive dec

Size comparison between 3-D printed prosthesis implant and a penny.

News | 3-D Printing | January 11, 2018
January 11, 2018 — Researchers using...
Overlay Init